Mettez-vous hors ligne avec l'application Player FM !
Make Way for Chinese Ozempic
Manage episode 422309634 series 3284624
Danish Novo Nordisk’s patent on semaglutide — the active ingredient in weight loss drug Ozempic expires in 2026. In the meantime, Chinese firms have been hard at work, trying to develop at least 15 generic versions of Ozempic and Wegovy. What does that mean for the pharmaceutical market?
In other news, a crisis is brewing at VIP industries as amid declining profits, Nisaba Godrej resigned as an independent director on the board of VIP Industries. What's happening to the legacy suitcase company VIP? Tune in!
681 episodes
Manage episode 422309634 series 3284624
Danish Novo Nordisk’s patent on semaglutide — the active ingredient in weight loss drug Ozempic expires in 2026. In the meantime, Chinese firms have been hard at work, trying to develop at least 15 generic versions of Ozempic and Wegovy. What does that mean for the pharmaceutical market?
In other news, a crisis is brewing at VIP industries as amid declining profits, Nisaba Godrej resigned as an independent director on the board of VIP Industries. What's happening to the legacy suitcase company VIP? Tune in!
681 episodes
Tüm bölümler
×Bienvenue sur Lecteur FM!
Lecteur FM recherche sur Internet des podcasts de haute qualité que vous pourrez apprécier dès maintenant. C'est la meilleure application de podcast et fonctionne sur Android, iPhone et le Web. Inscrivez-vous pour synchroniser les abonnements sur tous les appareils.